Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 98.33B | 99.30B | 98.46B | 98.46B | 88.79B | 114.24B |
Gross Profit | 6.65B | 6.62B | 6.68B | 6.77B | 5.93B | 6.80B |
EBITDA | 1.03B | 994.00M | 1.18B | 632.00M | -111.00M | 58.00M |
Net Income | 892.00M | 1.19B | 1.01B | 701.00M | -18.00M | 653.00M |
Balance Sheet | ||||||
Total Assets | 30.49B | 24.84B | 24.75B | 22.49B | 21.07B | 20.16B |
Cash, Cash Equivalents and Short-Term Investments | 3.11B | 3.00B | 4.34B | 2.93B | 2.28B | 3.58B |
Total Debt | 4.85B | 3.00B | 2.90B | 4.10B | 3.20B | 2.70B |
Total Liabilities | 19.73B | 13.38B | 14.70B | 14.26B | 13.52B | 12.49B |
Stockholders Equity | 10.76B | 11.46B | 10.04B | 8.23B | 7.55B | 7.67B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.34B | 2.57B | -402.00M | -2.11B | 222.00M |
Operating Cash Flow | 0.00 | -1.06B | 2.65B | -349.00M | -2.00B | 285.00M |
Investing Cash Flow | 0.00 | -296.00M | 227.00M | 123.00M | 280.00M | 338.00M |
Financing Cash Flow | 0.00 | 12.00M | -1.27B | 841.00M | 428.00M | -194.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥13.84B | 4.77 | 3.17% | 8.95% | 35.94% | ||
76 Outperform | ¥4.17B | 28.68 | ― | 8.10% | -26.53% | ||
75 Outperform | ¥2.96B | 11.47 | 1.83% | 14.88% | 8.27% | ||
69 Neutral | ¥4.53B | 3.87 | 1.76% | 0.86% | 17.20% | ||
67 Neutral | £10.36B | 6.03 | 4.94% | 3.22% | -0.88% | 2.57% | |
58 Neutral | ¥2.72B | 87.01 | 0.94% | 0.80% | -25.72% | ||
57 Neutral | ¥7.91B | 27.40 | 0.99% | 6.33% | 40.40% |